Definitive Healthcare Corp. DH
Set alert
1.12 USD 0.00 0.00%
At close · Oct 30
1.10 -0.02 -1.79%
After hours · Oct 30, 7:52 PM ET
1.09 Day range 1.14
0.628 52-week range 2.93
- YTD
- -60.98%
- 1 year
- -58.21%
- Open
- 1.14
- Prev close
- 1.12
- Mkt cap
- 119.55M
- Vol
- 447.91K
- Avg vol
- 626.40K
- EPS
- -1.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.09
- High
- 1.14
- Forward P/E
- 13.42
- Beta
- 1.33
- Short ratio
- 4.71
- Inst. own
- 95.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 4.41
- 200-d avg
- 5.36
- 1y target
- 5.25
2Y chart
Events in this range
- Nov 7, 2024Earnings: 0.1; estimate 0.08; surprise 25%
- Nov 8, 2024Rating: Needham · — → Hold
- Dec 20, 2024Rating: Stephens & Co. · — → Equal-Weight
Signals (68)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 19, 2026 | 1 week ago |
| RSI: Overbought | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| RSI: Overbought | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| RSI: Oversold | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 12, 2026 | 4 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| MACD: Sell Signal | May 14, 2026 | 5 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| RSI: Oversold | Feb 9, 2026 | 8 months ago |
| RSI: Oversold | Feb 5, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 18, 2025 | 10 months ago |
| RSI: Oversold | Dec 11, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 8, 2025 | 10 months ago |
| RSI: Oversold | Oct 30, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 24, 2025 | 1 year ago |
| RSI: Oversold | Oct 17, 2025 | 1 year ago |
| RSI: Oversold | Oct 9, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 24, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 4, 2025 | 1 year ago |
| SMA: Bullish | Sep 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| SMA: Bullish | Aug 27, 2025 | 1 year ago |
| SMA: Bearish | Aug 26, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 14, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Aug 8, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| RSI: Overbought | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 26, 2025 | 1 year ago |
| RSI: Overbought | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| RSI: Overbought | May 9, 2025 | 1 year ago |
| SMA: Bullish | May 8, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 20, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| RSI: Oversold | Feb 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
Key statistics
- Market cap
- 480.58M
- Enterprise value
- 622.31M
- Trailing P/E
- 0.00
- Forward P/E
- 13.42
- PEG ratio
- 0.00
- Price / sales
- 1.88
- Price / book
- 0.95
- EPS (TTM)
- -3.09
- Beta
- 1.33
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -142.38%
- Revenue (TTM)
- 255.85M
- Revenue growth
- -4.00%
- Free cash flow
- 91.06M
- Total cash
- 306.81M
- Total debt
- 257.19M
- Return on equity
- -54.77%
- Shares outstanding
- 115.52M
- Short % of float
- 4.73%
- 50-day average
- 4.41
- 200-day average
- 5.36
Analyst view
Consensus: buy
Buy
Price target (mean) 5.25 +368.7% upside
Now 1.12
- Target (low)
- 4.00
- Target (mean)
- 5.25
- Target (high)
- 7.00
Ratings (0m) 14 4 buy · 9 hold · 1 sell
- Strong buy0
- Buy4
- Hold9
- Sell0
- Strong sell1
Next earnings
Aug 5, 2024
Expected Aug 5, 2024. Consensus EPS estimate 0.0718.
Financials — quick view
DH Revenue — quarterly 55.20M
DH Net income — quarterly -5.42M
DH EPS — quarterly -0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.08 | 0.10 | +0.02 | +25.00% |
| Aug 5, 2024 | Jun 1, 2024 | 0.09 | — | — | — |
| Aug 5, 2024 | Jun 1, 2024 | 0.09 | 0.09 | 0.00 | 0.00% |
| May 7, 2024 | Mar 1, 2024 | 0.08 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.08 | 0.08 | 0.00 | 0.00% |
| Feb 28, 2024 | Dec 1, 2023 | 0.07 | 0.07 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Stephens & Co. | init | — | Equal-Weight |
| Nov 8, 2024 | Needham | reit | — | Hold |
| Sep 17, 2024 | BTIG | init | — | Buy |
| Aug 9, 2024 | Deutsche Bank | main | Hold | Hold |
| Aug 7, 2024 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 7, 2024 | Baird | main | Neutral | Neutral |
About Definitive Healthcare Corp.
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- definitivehc.com
News
- Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison
- Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
- Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
- Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop
- Definitive Healthcare Appoints Clay Ritchey as CEO
- Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison
- Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts
- Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5
Your note
Sign in to keep a note on DH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOOTH RICHARD DOUGLAS | Chief Financial Officer | Stock Award(Grant) | Nov 4, 2024 | 592,759 |
| CHILUKURI SASTRY | Director | Stock Award(Grant) | May 21, 2024 | 70,883 |
| COOP KEVIN | Chief Executive Officer | Stock Award(Grant) | Jul 2, 2024 | 1,356,240 |
| HAMOOD SAMUEL A | Director | Stock Award(Grant) | May 21, 2024 | 95,877 |
| KRANTZ JASON RONALD | Chief Executive Officer | Stock Award(Grant) | Feb 13, 2024 | 1,355,460 |
| LARSEN JILL | Director | Stock Award(Grant) | May 21, 2024 | 58,840 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Advent International LP | 54.10% | 62,493,676 | 259.97M | Sep 29, 2024 |
| Irenic Capital Management LP | 5.55% | 6,413,185 | 26.68M | Sep 29, 2024 |
| Massachusetts Financial Services Co. | 5.24% | 6,053,233 | 25.18M | Sep 29, 2024 |
| Vanguard Group Inc | 4.07% | 4,705,041 | 19.57M | Sep 29, 2024 |
| Blackrock Inc. | 4.03% | 4,652,288 | 19.35M | Sep 29, 2024 |
| Palisade Capital Management, L.P. | 1.99% | 2,294,579 | 9.55M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MFS New Discovery Fund | 3.20% | 3,696,877 | 15.38M | Aug 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.31% | 1,511,094 | 6.29M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.21% | 1,401,354 | 5.83M | Oct 30, 2024 |
| Vanguard Small-Cap Index Fund | 1.02% | 1,172,660 | 4.88M | Sep 29, 2024 |
| MFS Variable Insurance Trust-MFS New Discovery Series | 0.99% | 1,147,217 | 4.77M | Sep 29, 2024 |
| Pacific Select Fund-Small Cap Growth Portfolio | 0.71% | 824,012 | 3.43M | Sep 29, 2024 |